0001140361-14-030441.txt : 20140801 0001140361-14-030441.hdr.sgml : 20140801 20140801180624 ACCESSION NUMBER: 0001140361-14-030441 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140730 FILED AS OF DATE: 20140801 DATE AS OF CHANGE: 20140801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avalanche Biotechnologies, Inc. CENTRAL INDEX KEY: 0001501756 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 205258327 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1035 O?BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-272-6269 MAIL ADDRESS: STREET 1: 1035 O?BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hull Hans CENTRAL INDEX KEY: 0001614876 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36579 FILM NUMBER: 141011095 MAIL ADDRESS: STREET 1: C/O AVALANCHE BIOTECHNOLOGIES, INC. STREET 2: 1035 O'BRIEN DRIVE, SUITE A CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc1.xml FORM 4 X0306 4 2014-07-30 0 0001501756 Avalanche Biotechnologies, Inc. AAVL 0001614876 Hull Hans C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 0 1 0 0 SVP, Legal and Corp. Dev. Stock Option (Right to Buy) 17.00 2014-07-30 4 A 0 75000 0.00 A 2024-07-29 Common Stock 75000 75000 D Twenty-five percent (25%) of the total number of shares subject to the stock option shall vest and become exercisable one year after the Vesting Commencement Date, and one-forty-eighth (1/48th) of the total number of shares subject to the stock option shall vest and become exercisable monthly thereafter, so that all of the shares subject to the stock option shall be vested and exercisable on the fourth anniversary of July 30, 2014, subject to continuous service to the Issuer. /s/ Michael Swartzburg, Attorney-in-Fact for Hans Hull 2014-08-01